Expert panel seeks more data on Sputnik V Covid vaccine

‘No approval was given to Sputnik V on Thursday. Some queries have been asked on safety, efficacy, and logistics, which the firm will have answers to at the next meeting’ IMAGE:......

Sputnik V vaccine to be available in India from next week: Govt

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi. Photograph: Kind courtesy Russian Direct Investment Fund on Facebook Sputnik V, the......

Covid vaccine could cost up to Rs 1000 in private market

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private......

Apollo Hospitals launches pilot for Sputnik V vaccine

Apollo Hospitals and Dr Reddy's Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V. IMAGE: Second batch of Sputnik-V......

VinFast disrupts EV market with most affordable midsize SUV

VinFast's VF6 storms into India as the most affordable electric SUV above 4 metres, packing premium features, 468km range, and free charging till 2028 to disrupt the EV market, observes Somnath......

Indian Pharma Majors Ready With Weight Loss Drugs

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly. Kindly note the image has been posted only for representational purposes.......

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy’s Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company’s Q3 performance and......

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Dr Reddy’s Laboratories (DRL) is set to acquire Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.......